Category: Research

UNC Research recently published a feature on Dr. Jennifer Law and the Turner Syndrome research at UNC. In the 'Endeavors' article, "Hope for “Butterflies”, we learn more about how the UNC Turner Syndrome Clinic provides multidisciplinary care to improve the lives of patients, also known as “butterflies.”

This RTI/UNC-Chapel Hill collaboration will be the first US study offering genome sequencing and genetic risk scores for type 1 diabetes statewide. UNC School of Medicine leads are Cynthia Powell, MD and Jennifer Law, MD in Pediatrics. Early Check, a groundbreaking research study that provides free health tests to newborns...

A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.

Dr. Colin Orr, Assistant Professor of Pediatrics in General Pediatrics & Adolescent Medicine, received a K23 Career Development Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the United States National Institutes of Health. Dr. Orr's funded project is titled “Understanding and Addressing...

Investigators in Pediatric Pulmonology at UNC Children’s are playing key roles in the study and treatment of Cystic Fibrosis (CF). According to the Cystic Fibrosis Foundation, the current life expectancy for CF patients born between 2017 and 2021 is 53 years — a substantial change from just 10 years ago...

Dr. Melissa Bauserman, Associate Professor of Pediatrics in Neonatal-Perinatal Medicine, and her team recently received notice of renewal for the funding in support of the University of North Carolina-Kinshasa School of Public Health Research Partnership in the Democratic Republic of Congo; a Model for Improving Women's and Children's Health Through...

Michael Kappelman, MD, MPH, was the lead PI on the clinical trial, which followed nearly 300 children with Crohn’s to evaluate how their conditions changed in response to anti-TNF biologic treatments alone or in combination with a second immune suppressive medication.

A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

A UAB-UNC School of Medicine collaboration found that a single oral dose of the common antibiotic azithromycin reduced the risk of maternal sepsis or death by 33 percent in women who delivered vaginally. UNC School of Medicine study leads were Melissa Bauserman, MD, MPH, Carl Bose, MD, and Jackie Patterson,...

The V Foundation Board of Directors and Scientific Advisory Board has awarded funding to Ian Davis, MD, PhD, the G. Denman Hammond Professor of Childhood Cancer in the Division of Hematology/Oncology and a UNC Lineberger Comprehensive Cancer Center member, for his research project, “Novel mechanisms to improve CAR-T cell therapy...